US Patent 10774133 Anti-RSV monoclonal antibody formulation
Patent 10774133 was granted and assigned to Medimmune Limited on September, 2020 by the United States Patent and Trademark Office.
Is a
Date Filed
February 28, 2018
Date of Patent
September 15, 2020
Patent Application Number
15907876
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10774133 Anti-RSV monoclonal antibody formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.